Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Ezekowitz

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Cardiovascular Diabetology|August 2, 2024
Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathyPishoy Gouda, Yuxi Liu, Javed Butler, et al.
Clinical Cardiology|May 22, 2018
Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HFAmanda K Verma, Jie-Lena Sun, Adrian Hernandez, et al.
European Journal of Heart Failure|June 20, 2025
Implantable cardioverter-defibrillators in ischaemic versus non-ischaemic heart failure: Insights from the VICTORIA trialPishoy Gouda, Wendimagegn Alemayehu, Adriaan A Voors, et al.
The Canadian Journal of Cardiology|March 12, 2019
The Relationship Between Heart-Failure Hospitalization and Mortality in Patients Receiving Transcatheter Aortic Valve ReplacementHamed Nazzari, Nathaniel M Hawkins, Justin Ezekowitz, et al.
Plos One|May 27, 2015
Metabolomic fingerprint of heart failure with preserved ejection fractionBeshay N Zordoky, Miranda M Sung, Justin Ezekowitz, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 14, 2018
Effects of age, gender, and risk-factors for heart failure on native myocardial T<sub>1</sub> and extracellular volume fraction using the SASHA sequence at 1.5TJoseph J Pagano, Kelvin Chow, D Ian Paterson, et al.
American Heart Journal|January 28, 2010
Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trialRudolf Jarai, Kurt Huber, Kris Bogaerts, et al.
Current Problems in Cardiology|July 25, 2022
Clinical Phenotypes of Heart Failure across the spectrum of Ejection Fraction: A Cluster AnalysisPishoy Gouda, Wendimagegn Alemayehu, Sarah Rathwell, et al.
Cardiovascular Diabetology|January 13, 2025
Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trialThomas H Marwick, Carolyn Lam, Yuxi Liu, et al.
European Journal of Heart Failure|June 16, 2023
Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure RegistryNgoc V Nguyen, Felix Lindberg, Lina Benson, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Cardiovascular Diabetology|August 2, 2024
Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathyPishoy Gouda, Yuxi Liu, Javed Butler, et al.
Clinical Cardiology|May 22, 2018
Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HFAmanda K Verma, Jie-Lena Sun, Adrian Hernandez, et al.
European Journal of Heart Failure|June 20, 2025
Implantable cardioverter-defibrillators in ischaemic versus non-ischaemic heart failure: Insights from the VICTORIA trialPishoy Gouda, Wendimagegn Alemayehu, Adriaan A Voors, et al.
The Canadian Journal of Cardiology|March 12, 2019
The Relationship Between Heart-Failure Hospitalization and Mortality in Patients Receiving Transcatheter Aortic Valve ReplacementHamed Nazzari, Nathaniel M Hawkins, Justin Ezekowitz, et al.
Plos One|May 27, 2015
Metabolomic fingerprint of heart failure with preserved ejection fractionBeshay N Zordoky, Miranda M Sung, Justin Ezekowitz, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 14, 2018
Effects of age, gender, and risk-factors for heart failure on native myocardial T<sub>1</sub> and extracellular volume fraction using the SASHA sequence at 1.5TJoseph J Pagano, Kelvin Chow, D Ian Paterson, et al.
American Heart Journal|January 28, 2010
Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trialRudolf Jarai, Kurt Huber, Kris Bogaerts, et al.
Current Problems in Cardiology|July 25, 2022
Clinical Phenotypes of Heart Failure across the spectrum of Ejection Fraction: A Cluster AnalysisPishoy Gouda, Wendimagegn Alemayehu, Sarah Rathwell, et al.
Cardiovascular Diabetology|January 13, 2025
Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trialThomas H Marwick, Carolyn Lam, Yuxi Liu, et al.
European Journal of Heart Failure|June 16, 2023
Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure RegistryNgoc V Nguyen, Felix Lindberg, Lina Benson, et al.
Pageof 11